Search Within

Gregory J Riely

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (118)
  2. Meeting Abstract (94)
  3. Book Section (6)
  4. Research Letter (1)
Groups
  1. Department of Medicine (219)
  2. GSK Faculty (219)
  3. Human Oncology and Pathogenesis Program (219)
  4. Solid Tumor Oncology Division (219)
  5. Thoracic Oncology (219)
  6. Department of Pathology and Laboratory Medicine (203)

More Groups

People
  1. Marc Ladanyi (187)
  2. Mark Kris (128)
  3. Maria Arcila (78)
  4. Helena Yu (65)
  5. Charles Rudin (61)
  6. Natasha Rekhtman (50)

More People

Years
  1. 2024 (10)
  2. 2023 (18)
  3. 2022 (12)
  4. 2021 (15)
  5. 2020 (14)
  6. 2019 (19)

More Years

Publications
  1. Journal of Clinical Oncology (59)
  2. Journal of Thoracic Oncology (33)
  3. Clinical Cancer Research (30)
  4. JCO Precision Oncology (9)
  5. Annals of Oncology (8)
  6. Cancer Research (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (68)
  2. American Association for Cancer Research (48)
  3. Elsevier Inc. (35)
  4. Nature Publishing Group (13)
  5. Oxford University Press (11)
  6. Elsevier Science, Inc. (9)

More Publishers

Results (219)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of the characteristics and clinical course of 677 patients with metastatic lung cancers with mutations in KRAS codons 12 and 13
    Meeting Abstract

    Yu, H. A.; Sima, C. S.; Shen, R. L.; Kass, S. L.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Response to erlotinib and prognosis for patients with de novo epidermal growth factor receptor (EGFR) T790M mutations
    Meeting Abstract

    Riely, G. J.; Yu, H. A.; Arcila, M. E.; Hellmann, M. D.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A retrospective analysis of the prevalence of EGFR or KRAS mutations in patients (pts) with crizotinib-naive and crizotinib-resistant, ALK-positive non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Gainor, J. F.; Varghese, A. M.; Ou, S. H. I.; Kabraji, S.; Awad, M. M.; Katayama, R.; Pawlak, A.; Mino-Kenudson, M.; Yeap, B. Y.; Riely, G. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Screening for RET and ROS1 fusions in an enriched cohort of pan-negative never-smokers with advanced lung adenocarcinomas to identify patients for treatment in targeted therapy trials
    Meeting Abstract

    Drilon, A. E. D.; Wang, L.; Hasanovic, A.; Joubert, P.; Kris, M. G.; Riely, G. J.; Ladanyi, M.; Rizvi, N. A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Comparison of the characteristics and clinical course of patients with metastatic KRAS mutant lung cancers
    Meeting Abstract

    Riely, G.; Yu, H. A.; Sima, C. S.; Shen, R. L.; Kass, S. L.; Kris, M. G.; Ladanyi, M.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Prospective molecular evaluation of small cell lung cancer (SCLC) utilizing the comprehensive mutation analysis Program at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Pietanza, M. C.; Varghese, A.; Won, H.; Rekhtman, N.; Wang, L.; Travis, W. D.; Paik, P. K.; Riely, G. J.; Zakowski, M. F.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Ret fusion-positive advanced lung cancers: Response to first-line chemotherapy and survival in comparison to ROS1 and ALK fusion-positive and EGFR- and KRAS-mutant lung cancers
    Meeting Abstract

    Drilon, A.; Wang, L.; Joubert, P.; Snyder, A.; Cho, E. J.; Riely, G.; Kris, M.; Ladanyi, M.; Rizvi, N.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Targeted cancer genome sequencing in thymic epithelial tumors
    Meeting Abstract

    Moreira, A.; McMillan, R.; Won, H.; Huang, J.; Riely, G.; Ladanyi, M.; Berger, M.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Systematic evaluation of KRAS mutation detection using an AmpliSeq custom panel and ion torrent sequencing in 113 KRAS-mutated lung cancers
    Meeting Abstract

    Borsu, L.; Cavatore, M.; Yannes, A.; Brzostowski, E.; Casanova, J.; Lailler, N.; Cheng, D.; Viale, A.; Yu, H.; Riely, G.; more...
    Journal of Molecular Diagnostics (2013)

    Fulltext@MSK | Save
  • KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma
    Journal Article

    Rekhtman, N.; Ang, D. C.; Riely, G. J.; Ladanyi, M.; Moreira, A. L.
    Modern Pathology (2013)

    Fulltext@MSK | Save